Refining of the electroclinical phenotype in familial and sporadic cases of CSNK2B-related Neurodevelopmental Syndrome.

CSNK2B encodes a regulatory subunit of casein kinase II, which is highly expressed in the brain. Heterozygous pathogenic variants in CSNK2B are associated with Poirier-Bienvenu neurodevelopmental syndrome (POBINDS) (OMIM #618732), characterized by facial dysmorphisms, seizures, intellectual disability, and behavioral disturbances. We report ten new patients with CSNK2B-related Neurodevelopmental Syndrome associated with heterozygous variants of CSNK2B. In three patients, a pathogenic variant was inherited from an affected parent. We describe both molecular and clinical features, focusing on epileptic and neurodevelopmental phenotypes. The median age at follow-up was 8.5 years (range 21 months-42 years). All patients had epilepsy, with onset at a median age of 10.5 months range 6 days-10 years). Seizures were both focal and generalized and were resistant to anti-seizure medications in two out of ten patients. Six patients had mild to moderate cognitive delays, whereas four patients had no cognitive disability. Although all previously reported patients had a de novo CSNK2B pathogenic variant, here we report, for the first time, two familial cases of CSNK2B-related Neurodevelopmental Syndrome. We confirmed the highly variable expressivity of the disease among both interfamilial and intrafamilial cases. Furthermore, this study provides information about the long-term outcome in adult patients and underlines the importance of detailed family history collection before performing genetic testing in patients with epilepsy and neurodevelopmental disorders.

• Publication year

  2023

• Venue

  Epilepsy & Behavior

• Publication date

  2023-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.yebeh.2023.109436PMID 37717460
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Case report: Two cases of Poirier-Bienvenu neurodevelopmental syndrome and review of literature

  2023cited by this paper
• Predictive functional, statistical and structural analysis of CSNK2A1 and CSNK2B variants linked to neurodevelopmental diseases

  2022cited by this paper
• Two different presentations of de novo variants of CSNK2B: two case reports

  2022cited by this paper
• De novo variants of CSNK2B cause a new intellectual disability-craniodigital syndrome by disrupting the canonical Wnt signaling pathway

  2022cited by this paper
• De Novo CSNK2B Mutations in Five Cases of Poirier–Bienvenu Neurodevelopmental Syndrome

  2022cited by this paper
• Expanding Phenotype of Poirier–Bienvenu Syndrome: New Evidence from an Italian Multicentrical Cohort of Patients

  2022cited by this paper
• Splicing Interruption by Intron Variants in CSNK2B Causes Poirier–Bienvenu Neurodevelopmental Syndrome: A Focus on Genotype–Phenotype Correlations

  2022cited by this paper
• 6p21.33 Deletion encompassing CSNK2B is associated with relative macrocephaly, facial dysmorphism, and mild intellectual disability.

  2021cited by this paper
• Developmental and epilepsy spectrum of Poirier-Bienvenu neurodevelopmental syndrome: Description of a new case study and review of the available literature.

  2021cited by this paper
• Clinical and genetic analysis of six Chinese children with Poirier-Bienvenu neurodevelopmental syndrome caused by CSNK2B mutation

  2021cited by this paper
• CSNK2B: A broad spectrum of neurodevelopmental disability and epilepsy severity

  2021cited by this paper
• Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients

  2021cited by this paper
• Poirier–Bienvenu neurodevelopmental syndrome: A report of a patient with a pathogenic variant in CSNK2B with abnormal linear growth

  2020cited by this paper
• Germline de novo variants in CSNK2B in Chinese patients with epilepsy

  2019cited by this paper
• Protein Kinase CK2 Subunits Differentially Perturb the Adhesion and Migration of GN11 Cells: A Model of Immature Migrating Neurons

  2019cited by this paper
• Identification of de novo CSNK2A1 and CSNK2B variants in cases of global developmental delay with seizures

  2019cited by this paper
• The management of epilepsy in children and adults

  2018cited by this paper
• Author Correction: Comprehensive integrative analyses identify GLT8D1 and CSNK2B as schizophrenia risk genes

  2018cited by this paper
• VarSome: the human genomic variant search engine

  2018cited by this paper
• CSNK2B splice site mutations in patients cause intellectual disability with or without myoclonic epilepsy

  2017cited by this paper
• Truncating mutation in CSNK2B and myoclonic epilepsy

  2017cited by this paper
• Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology

  2017cited by this paper
• Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis

  2016cited by this paper
• Familial neonatal seizures in 36 families: Clinical and genetic features correlate with outcome

  2015cited by this paper
• KBG Syndrome: A Case Report and Longitudinal Assessment of Long‐Acting Recombinant Human Growth Hormone Therapy

  2015cited by this paper
• Cooperative modulation of protein kinase CK2 by separate domains of its regulatory beta-subunit.

  2000cited by this paper

• Effect of sex on neuropsychiatric comorbidities in childhood epilepsy.

  2025cites this paper
• A case of Poirier-Bienvenu neurodevelopmental syndrome with non-epileptic seizures, phonophobia, and autism spectrum disorder

  2025cites this paper
• CSNK2B Mutation: A Rare Cause of IGHD

  2024cites this paper
• Antiepileptic drugs

  2023cites this paper